News
AstraZeneca’s top medical executive Cristian Massacesi will replace Bristol Myers’ current chief medical officer, Samit ...
Bristol Myers is making waves after a period of pressure. The stock jumped 6.3% recently, outperforming its industry and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback